Provided by Tiger Trade Technology Pte. Ltd.

Denali Therapeutics Inc.

24.97
+0.77003.18%
Volume:319.92K
Turnover:8.01M
Market Cap:3.99B
PE:-8.81
High:25.26
Open:24.86
Low:24.81
Close:24.20
52wk High:27.30
52wk Low:12.58
Shares:159.85M
Float Shares:151.07M
Volume Ratio:0.60
T/O Rate:0.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8353
EPS(LYR):-2.9700
ROE:-54.93%
ROA:-29.15%
PB:4.78
PE(LYR):-8.41

Loading ...

Aug 11, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2026

Major Issues Report

Form 8-K - Current report
Aug 04, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 28, 2026

Major Issues Report

Form 8-K - Current report
Jul 08, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 18, 2026

Major Issues Report

Form 8-K - Current report
Jun 04, 2026

Major Issues Report

Form 8-K - Current report
May 22, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 08, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 03, 2026

Major Issues Report

Form 8-K - Current report
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 25, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities